
Dr Agarwal’s Healthcare made a flat debut on the NSE, with its stock listing at ₹402, exactly matching the upper end of its IPO price band of ₹382-402 per share. The IPO, amounting to ₹3,027.26 crore, included a fresh issue of 0.75 crore shares worth ₹300 crore and an offer for sale of 6.78 crore shares worth ₹2,727.26 crore.
Key Strengths of Dr Agarwal’s Healthcare:
- India’s largest eye care services provider with a trusted brand reputation.
- Comprehensive end-to-end eye care services.
- Scalable, asset-light, hub-and-spoke operational model.
- Proven clinical excellence, backed by an experienced clinical board and history of surgical innovations.
- Doctor-led promoters with a team of qualified medical professionals and experienced management.
- Strong history of organic growth, acquisition integration, and operating profitability enhancement.
IPO Details:
- Price Band: ₹382-₹402 per share
- Minimum Lot Size:
- Retail Investors: 35 shares requiring an investment of at least ₹14,070
- Small Non-Institutional Investors (sNII): 15 lots (525 shares) worth ₹2,11,050
- Big Non-Institutional Investors (bNII): 72 lots (2,520 shares) totaling ₹10,13,040
Book-Running Lead Managers:
Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors. KFin Technologies served as the registrar for the issue.